A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH. Klotsman M, Weinberg CR, Davis K, Binnie CG, Hartmann KE (2004) Pharmacogenomics J 4: 251-9 NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Austin DC, Strand DW, Love HL, Franco OE, Grabowska MM, Miller NL, Hameed O, Clark PE, Matusik RJ, Jin RJ, Hayward SW (2016) Prostate 76: 1004-18 Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. Nichol MB, Knight TK, Wu J, Barron R, Penson DF (2009) J Urol 181: 2214-21; discussion 2221-2 Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature. Neuhouser ML, Kristal AR, Penson DF (2004) Urology 64: 201-11
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.